Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2026-02-03 @ 9:59 AM
Study NCT ID:
NCT04088032
Status:
WITHDRAWN
Last Update Posted:
2020-07-16
First Post:
2019-09-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer
Sponsor:
Alison Stopeck
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2019-00174 Neoadj Breast Pilot
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None